{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:16:41Z","timestamp":1794435401428,"version":"4.9.1"},"reference-count":56,"publisher":"National Academy of Sciences","issue":"28","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA196988"],"award-info":[{"award-number":["R01 CA196988"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL118390"],"award-info":[{"award-number":["R01 HL118390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000983","name":"Mary Kay Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA134274"],"award-info":[{"award-number":["P30CA134274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA254938"],"award-info":[{"award-number":["R01 CA254938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-16-123-13"],"award-info":[{"award-number":["IRG-16-123-13"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA154274"],"award-info":[{"award-number":["T32CA154274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008181"],"award-info":[{"award-number":["T32GM008181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2022,7,12]]},"abstract":"<jats:p>Treatments for advanced and recurrent ovarian cancer remain a challenge due to a lack of potent, selective, and effective therapeutics. Here, we developed the basis for a transformative anticancer strategy based on anthrax toxin that has been engineered to be selectively activated by the catalytic power of zymogen-activating proteases on the surface of malignant tumor cells to induce cell death. Exposure to the engineered toxin is cytotoxic to ovarian tumor cell lines and ovarian tumor spheroids derived from patient ascites. Preclinical studies demonstrate that toxin treatment induces tumor regression in several in\u00a0vivo ovarian cancer models, including patient-derived xenografts, without adverse side effects, supportive of progression toward clinical evaluation. These data lay the groundwork for developing therapeutics for treating women with late-stage and recurrent ovarian cancers, utilizing a mechanism distinct from current anticancer therapies.<\/jats:p>","DOI":"10.1073\/pnas.2201423119","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T14:40:47Z","timestamp":1657291247000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":10,"title":["Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases"],"prefix":"10.1073","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9066-8191","authenticated-orcid":false,"given":"Nadire","family":"Duru","sequence":"first","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Pawar","sequence":"additional","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-2378","authenticated-orcid":false,"given":"Erik W.","family":"Martin","sequence":"additional","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite S.","family":"Buzza","sequence":"additional","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-887X","authenticated-orcid":false,"given":"Gregory D.","family":"Conway","sequence":"additional","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-743X","authenticated-orcid":false,"given":"Rena G.","family":"Lapidus","sequence":"additional","affiliation":[{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-1069","authenticated-orcid":false,"given":"Shihui","family":"Liu","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Reader","sequence":"additional","affiliation":[{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam G.","family":"Rao","sequence":"additional","affiliation":[{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Roque","sequence":"additional","affiliation":[{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-0501","authenticated-orcid":false,"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni M.","family":"Antalis","sequence":"additional","affiliation":[{"name":"Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201"},{"name":"Research &amp; Development Service, VA Maryland Health Care System, Baltimore, MD 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4019"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13551"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01009"},{"key":"e_1_3_4_4_2","first-page":"1271","article-title":"Bevacizumab in recurrent ovarian cancer","volume":"26","author":"Sait Bakir M.","year":"2021","unstructured":"M. Sait Bakir , Bevacizumab in recurrent ovarian cancer. J. BUON 26, 1271\u20131278 (2021).","journal-title":"J. BUON"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100105"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081044"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1745"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052514"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62339-7"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2020.03.011"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2410"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad0293"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20100046"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R109.021006"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-019-09811-7"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8070197"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins5010001"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-003-8_7"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.1999.00890.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.540"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00201-13"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201402290"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.019"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5364.734"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj20031382"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)49569-0"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2003.08.003"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.1.82-87.1995"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5214"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.26502\/ogr072"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12647"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0317-x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-019-01763-3"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.5"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011085200"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00801-4"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.250647.114"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15227"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28864"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0470"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2245"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt463"},{"key":"e_1_3_4_44_2","first-page":"PO.18.00025","article-title":"BRAF mutations occur infrequently in ovarian cancer but suggest responsiveness to BRAF and MEK inhibition","volume":"2","author":"Campos M. P.","year":"2018","unstructured":"M. P. Campos , BRAF mutations occur infrequently in ovarian cancer but suggest responsiveness to BRAF and MEK inhibition. JCO Precis. Oncol. 2, PO.18.00025 (2018).","journal-title":"JCO Precis. Oncol."},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604783"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031102"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2567"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01025-7"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0347"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.03.009"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046858"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2011.05.016"},{"key":"e_1_3_4_53_2","unstructured":"N. Duru . Engineered anthrax protective antigen proteins for cancer therapy. NCBI. https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/LQ782047.1. Deposited 27 June 2018."},{"key":"e_1_3_4_54_2","unstructured":"N. Duru . Engineered anthrax protective antigen proteins for cancer therapy. NCBI. https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/LQ782049.1. Deposited 27 June 2018."},{"key":"e_1_3_4_55_2","unstructured":"N. Duru . Engineered anthrax protective antigen proteins for cancer therapy. NCBI. https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/LQ782045.1. Deposited 27 June 2018."},{"key":"e_1_3_4_56_2","unstructured":"N. Duru . Engineered anthrax protective antigen proteins for cancer therapy. NCBI. https:\/\/www.ncbi.nlm.nih.gov\/nuccore\/LQ782063.1. Deposited 27 June 2018."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2201423119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T14:41:13Z","timestamp":1657291273000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2201423119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":56,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2022,7,12]]}},"alternative-id":["10.1073\/pnas.2201423119"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2201423119","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"2022-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2201423119"}}